[Duhring-Brocq disease treated by combined aureomycin-nivaquine and maintained by nivaquine alone].
D002738:Chloroquine; D002751:Chlortetracycline / Q000627:therapeutic use*; D003874:Dermatitis Herpetiformis / Q000628:therapy*; D011804:Quinolines / Q000627:therapeutic use*; D014528:Uricosuric Agents
D011804:Quinolines; D014528:Uricosuric Agents; D002738:Chloroquine; D002751:Chlortetracycline
CHLORTETRACYCLINE/therapeutic use; DERMATITIS HERPETIFORMIS/therapy; QUINOLINES/therapeutic use
Maladie de Duhring-Brocq blanchie par l'association auréomycine-nivaquine et maintenue par la nivaquine seule.